[{"address1": "601 Brickell Key Drive", "address2": "Suite 1000", "city": "Miami", "state": "FL", "zip": "33131", "country": "United States", "phone": "305 203 2034", "website": "https://www.smmttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.", "fullTimeEmployees": 159, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert W. Duggan", "age": 80, "title": "Co-CEO & Executive Chairman", "yearBorn": 1944, "fiscalYear": 2024, "totalPay": 158613, "exercisedValue": 0, "unexercisedValue": 1133457}, {"maxAge": 1, "name": "Dr. Mahkam  Zanganeh D.D.S., M.B.A.", "age": 54, "title": "Co-CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1161021, "exercisedValue": 0, "unexercisedValue": 128563160}, {"maxAge": 1, "name": "Mr. Manmeet Singh Soni CPA", "age": 46, "title": "COO, CFO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1261021, "exercisedValue": 0, "unexercisedValue": 107858016}, {"maxAge": 1, "name": "Prof. Dame Kay Davies DBE, FRS CBE", "age": 73, "title": "Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Gancarz", "title": "Chief Business & Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fong  Clow", "title": "Chief Biometrics Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shelley D. Spray", "age": 59, "title": "Chief Education & Brand Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Urte  Gayko Ph.D.", "age": 53, "title": "Chief Regulatory, Quality & Pharmacovigilance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Allen S. Yang M.D., Ph.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laura Q. M. Chow M.D.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 26.45, "open": 26.49, "dayLow": 25.85, "dayHigh": 27.45, "regularMarketPreviousClose": 26.45, "regularMarketOpen": 26.49, "regularMarketDayLow": 25.85, "regularMarketDayHigh": 27.45, "payoutRatio": 0.0, "beta": -1.06, "forwardPE": -70.23685, "volume": 2585985, "regularMarketVolume": 2585985, "averageVolume": 3905141, "averageVolume10days": 3240060, "averageDailyVolume10Day": 3240060, "bid": 26.64, "ask": 27.09, "bidSize": 19, "askSize": 19, "marketCap": 19826585600, "fiftyTwoWeekLow": 11.29, "fiftyTwoWeekHigh": 36.91, "fiftyDayAverage": 24.4059, "twoHundredDayAverage": 21.7253, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 19534258176, "profitMargins": 0.0, "floatShares": 116233219, "sharesOutstanding": 742846976, "sharesShort": 30994739, "sharesShortPriorMonth": 27048734, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0417, "heldPercentInsiders": 0.84300005, "heldPercentInstitutions": 0.13536, "shortRatio": 9.58, "shortPercentOfFloat": 0.26569998, "impliedSharesOutstanding": 742846976, "bookValue": 0.349, "priceToBook": 76.47565, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -746078016, "trailingEps": -1.01, "forwardEps": -0.38, "enterpriseToEbitda": -25.731, "52WeekChange": 1.1787755, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 26.69, "targetHighPrice": 44.04218, "targetLowPrice": 12.129797, "targetMeanPrice": 35.163017, "targetMedianPrice": 35.101723, "recommendationMean": 1.45455, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 297872000, "totalCashPerShare": 0.401, "ebitda": -759176000, "totalDebt": 5553000, "quickRatio": 4.938, "currentRatio": 5.126, "debtToEquity": 2.14, "returnOnAssets": -1.4253, "returnOnEquity": -3.28297, "freeCashflow": 41463624, "operatingCashflow": -206882000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SMMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekChangePercent": 117.877556, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.01, "epsForward": -0.38, "epsCurrentYear": -0.46386, "priceEpsCurrentYear": -57.538914, "fiftyDayAverageChange": 2.2841015, "fiftyDayAverageChangePercent": 0.09358809, "twoHundredDayAverageChange": 4.9647007, "twoHundredDayAverageChangePercent": 0.22852162, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Summit Therapeutics plc", "nameChangeDate": "2025-08-15", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 0.907371, "regularMarketPrice": 26.69, "marketState": "CLOSED", "shortName": "Summit Therapeutics Inc.", "longName": "Summit Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1425565800000, "postMarketChangePercent": -0.711879, "postMarketPrice": 26.5, "postMarketChange": -0.190001, "regularMarketChange": 0.24, "regularMarketDayRange": "25.85 - 27.45", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3905141, "fiftyTwoWeekLowChange": 15.400001, "fiftyTwoWeekLowChangePercent": 1.3640391, "fiftyTwoWeekRange": "11.29 - 36.91", "fiftyTwoWeekHighChange": -10.219999, "fiftyTwoWeekHighChangePercent": -0.2768897, "corporateActions": [], "postMarketTime": 1755301079, "regularMarketTime": 1755288000, "exchange": "NGM", "messageBoardId": "finmb_11611587", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Summit Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]